Evidence map›Paper›PMID 10364579›Full record

ArticleJournal of clinical microbiology1999

Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.

C van Pelt, C M Verduin, W H Goessens, M C Vos, B Tümmler, C Segonds, F Reubsaet, H Verbrugh, A van Belkum

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of clinical microbiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Rapid and Simple Detection ofFoods (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Article
  5. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2019
    Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Burkholderia gladioli infection isolated from the blood cultures of newborns in the neonatal intensive care unit.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
  11. Ralstonia spp.: emerging global opportunistic pathogens.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2014
    Review
  12. Review
  13. Burkholderia gladioli sepsis in newborns.European journal of pediatrics · 2012
    Article
  14. Differentiating the growing nosocomial infectious threats Ralstonia pickettii and Ralstonia insidiosa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2011
    Article
  15. Article
  16. Article
  17. The changing microbial epidemiology in cystic fibrosis.Clinical microbiology reviews · 2010
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

C van PeltDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam EMCR, 3015 GD Rotterdam, The Netherlands. vanpelt@bacl.azr.nl
C M Verduin
W H Goessens
M C Vos
B Tümmler
C Segonds
F Reubsaet
H Verbrugh
A van Belkum
Erasmus MC · NLHôpital Rangueil · FRMedizinische Hochschule Hannover · DENational Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) predisposes patients to bacterial colonization and infection of the lower airways. Several species belonging to the genus Burkholderia are potential CF-related pathogens, but microbiological identification may be complicated. This situation is not in the least due to the poorly defined taxonomic status of these bacteria, and further validation of the available diagnostic assays is required. A total of 114 geographically diverse bacterial isolates, previously identified in reference laboratories as Burkholderia cepacia (n = 51), B. gladioli (n = 14), Ralstonia pickettii (n = 6), B. multivorans (n = 2), Stenotrophomonas maltophilia (n = 3), and Pseudomonas aeruginosa (n = 11), were collected from environmental, clinical, and reference sources. In addition, 27 clinical isolates putatively identified as Burkholderia spp. were recovered from the sputum of Dutch CF patients. All isolates were used to evaluate the accuracy of two selective growth media, four systems for biochemical identification (API 20NE, Vitek GNI, Vitek NFC, and MicroScan), and three different PCR-based assays. The PCR assays amplify different parts of the ribosomal DNA operon, either alone or in combination with cleavage by various restriction enzymes (PCR-restriction fragment length polymorphism [RFLP] analysis). The best system for the biochemical identification of B. cepacia appeared to be the API 20NE test. None of the biochemical assays successfully grouped the B. gladioli strains. The PCR-RFLP method appeared to be the optimal method for accurate nucleic acid-mediated identification of the different Burkholderia spp. With this method, B. gladioli was also reliably classified in a separate group. For the laboratory diagnosis of B. cepacia, we recommend parallel cultures on blood agar medium and selective agar plates. Further identification of colonies with a Burkholderia phenotype should be performed with the API 20NE test. For final confirmation of species identities, PCR amplification of the small-subunit rRNA gene followed by RFLP analysis with various enzymes is recommended.

Indexed as

Bacterial Typing TechniquesBase SequenceBurkholderiaBurkholderia cepaciaBurkholderia InfectionsCystic FibrosisDNA, RibosomalGeographyHumansMolecular Sequence DataPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthPseudomonas aeruginosaRestriction MappingRNA, Ribosomal, 16SSequence AlignmentDNA, RibosomalRNA, Ribosomal, 16S

Identifiers

PMID10364579
PMCPMC85108
OpenAlexW2136365752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.